Annual Securities Report — FY2025
What Soiken Holdings Inc. reported for the period from 2025-07-01 to 2026-06-30. Filed by 株式会社総医研ホールディングス
Filed 2026-09-24View the original on EDINET
How much it says
54Typical
What moved here
18named for the first time
Its own wording
50terms
Which filing this is
33/ 33newest
No officer data yetThis company's filings have not been read for officers yet. Nothing is missing from the filings — the roster simply has not been extracted.
The gist
During the consolidated fiscal year, the Group advanced business reorganization, including the cosmetics business, through withdrawal from the Chinese market and the termination and transfer of businesses at related subsidiaries, and the functional materials development business through the absorption-type merger of NRL Pharma. It also recognized income and expenses related to structural reforms, including the transfer of trademark rights and voluntary retirement programs.
Komori's summary of this document, not the document's own words.54Typical
How much this filing saysA weighted roll-up of 12 rubric dimensions, each scored from a fixed set of questions asked against this filing — built only from the 39 this document could answer. It measures how specific the disclosure is, not whether the company is doing well. Derived from the data, not editorial.
96
Very detailed
68
Detailed
22
Almost nothing
88
Very detailed
12
Almost nothing
100
Very detailed
32
Thin
27
Almost nothing
33
Thin
13
Almost nothing
35
Thin
100
Very detailed
How to read this page
This is not the documentIt is Komori's reading of the filing submitted to EDINET. The original is linked above.
The score is not a verdictIt measures how specific the disclosure is. It says nothing about results or where the share price goes.
When it updatesContent lands once the filing has been read through. Right after submission, the summary can still be empty.